Patient‐reported outcomes in Friedreich’s ataxia after withdrawal from idebenone

Abstract

This study provides no data to suggest that FRDA patients could correctly determine their treatment assignment over a 2-month period. We hope that this study design will help inform future trials so that patients' experiences of symptoms are more reliably measured.